Lehre & Forschung

Gerne informieren wir Sie über die aktuellen Studien des Schlaganfallzentrums.

BIOSIGNAL

Biomarker signature of stroke aetiology study.

Status: current, recruiting completed

CAPSAICIN

Capsaicin for post-stroke dysphagia (CADYS). The aim of this multicenter, randomizes, double-blind study is to examine the effect of Capsaicin treatment in the setting of (sub-)acute stroke, compared to placebo.

Status: planned

CISS

Effects of serotonergic neuromodulation on behavioural recovery and motor network plasticity after cortical ischemic stroke: a longitudinal, placebo-controlled study.

Status: current

ECST

The 2nd European Carotid Surgery Trial.

Status: planned

ELAN

Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): an international, multicentre, randomised-controlled, two-arm, assessor-blinded Trial.

Status: current

eSATIS

Early Sleep Apnea Treatment in Stroke: A Randomized, Rater-Blinded, Clinical Trial of Adaptive Servo-Ventilation.

Status: current

ESTREL

Enhancement of Stroke Rehabilitation with Levodopa (ESTREL): a randomized placebo-controlled Trial.

Status: planned

Swiss Stroke Registry (SSR)

Schweizweite Datenbank zum akuten Schlaganfall.

Status: current

TICH NOAC

Treatment of intracerebral hemorrhage in patients on non-vitamin K oral anticoagulants with tranexamic acid.

Status: current

TREAT-CAD

Biomarker und antithrombotische Therapie bei Dissektion der hirnzuführenden Gefässe (TREAT-CAD).

Status: current, recruiting completed

 

Informieren Sie sich über die Forschungsaktivitäten des Kantonsspitals St.Gallen und melden Sie Probandinnen und Probanden für Studien an: